Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Jun 1;380(Pt 2):435–440. doi: 10.1042/BJ20031714

Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids.

Arkaitz Carracedo 1, Math J H Geelen 1, María Diez 1, Kentaro Hanada 1, Manuel Guzmán 1, Guillermo Velasco 1
PMCID: PMC1224177  PMID: 14979873

Abstract

Cannabinoids induce apoptosis on glioma cells via stimulation of ceramide synthesis de novo, whereas they do not affect viability of primary astrocytes. In the present study, we show that incubation with Delta9-tetrahydrocannabinol did not induce accumulation of ceramide on astrocytes, although incubation of these cells in a serum-free medium (with or without cannabinoids) led to stimulation of ceramide synthesis de novo and sensitization to oxidative stress. Thus treatment with H2O2 induced apoptosis of 5-day-serum-deprived astrocytes and this effect was abrogated by pharmacological blockade of ceramide synthesis de novo. The sensitizing effect of ceramide accumulation may depend on p38 mitogen-activated protein kinase activation rather than on other ceramide targets. Finally, a protective role of cannabinoids on astrocytes is shown as a long-term incubation with cannabinoids prevented H2O2-induced loss of viability in a CB1 receptor-dependent manner. In summary, our results show that whereas challenge of glioma cells with cannabinoids induces accumulation of de novo -synthesized ceramide and apoptosis, long-term treatment of astrocytes with these compounds does not stimulate this pathway and also abrogates the sensitizing effects of ceramide accumulation.

Full Text

The Full Text of this article is available as a PDF (385.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker David, Pryce Gareth. The therapeutic potential of cannabis in multiple sclerosis. Expert Opin Investig Drugs. 2003 Apr;12(4):561–567. doi: 10.1517/13543784.12.4.561. [DOI] [PubMed] [Google Scholar]
  2. Blázquez C., Galve-Roperh I., Guzmán M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J. 2000 Nov;14(14):2315–2322. doi: 10.1096/fj.00-0122com. [DOI] [PubMed] [Google Scholar]
  3. Blázquez C., Geelen M. J., Velasco G., Guzmán M. The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett. 2001 Feb 2;489(2-3):149–153. doi: 10.1016/s0014-5793(01)02089-0. [DOI] [PubMed] [Google Scholar]
  4. Bouaboula M., Poinot-Chazel C., Bourrié B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., Casellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J. 1995 Dec 1;312(Pt 2):637–641. doi: 10.1042/bj3120637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buzas Beata. Regulation of nociceptin/orphanin FQ gene expression in astrocytes by ceramide. Neuroreport. 2002 Oct 7;13(14):1707–1710. doi: 10.1097/00001756-200210070-00003. [DOI] [PubMed] [Google Scholar]
  6. Derkinderen P., Toutant M., Burgaya F., Le Bert M., Siciliano J. C., de Franciscis V., Gelman M., Girault J. A. Regulation of a neuronal form of focal adhesion kinase by anandamide. Science. 1996 Sep 20;273(5282):1719–1722. doi: 10.1126/science.273.5282.1719. [DOI] [PubMed] [Google Scholar]
  7. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992 Dec 18;258(5090):1946–1949. doi: 10.1126/science.1470919. [DOI] [PubMed] [Google Scholar]
  8. Freund Tamas F., Katona Istvan, Piomelli Daniele. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev. 2003 Jul;83(3):1017–1066. doi: 10.1152/physrev.00004.2003. [DOI] [PubMed] [Google Scholar]
  9. Galve-Roperh I., Sánchez C., Cortés M. L., Gómez del Pulgar T., Izquierdo M., Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med. 2000 Mar;6(3):313–319. doi: 10.1038/73171. [DOI] [PubMed] [Google Scholar]
  10. Goldkorn T., Balaban N., Shannon M., Chea V., Matsukuma K., Gilchrist D., Wang H., Chan C. H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J Cell Sci. 1998 Nov;111(Pt 21):3209–3220. doi: 10.1242/jcs.111.21.3209. [DOI] [PubMed] [Google Scholar]
  11. Guzmán Manuel. Cannabinoids: potential anticancer agents. Nat Rev Cancer. 2003 Oct;3(10):745–755. doi: 10.1038/nrc1188. [DOI] [PubMed] [Google Scholar]
  12. Gómez Del Pulgar Teresa, De Ceballos Maria L., Guzmán Manuel, Velasco Guillermo. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem. 2002 Jul 19;277(39):36527–36533. doi: 10.1074/jbc.M205797200. [DOI] [PubMed] [Google Scholar]
  13. Gómez del Pulgar T., Velasco G., Guzmán M. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J. 2000 Apr 15;347(Pt 2):369–373. doi: 10.1042/0264-6021:3470369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gómez del Pulgar Teresa, Velasco Guillermo, Sánchez Cristina, Haro Amador, Guzmán Manuel. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J. 2002 Apr 1;363(Pt 1):183–188. doi: 10.1042/0264-6021:3630183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hampson A. J., Grimaldi M., Axelrod J., Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8268–8273. doi: 10.1073/pnas.95.14.8268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hanada Kentaro. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta. 2003 Jun 10;1632(1-3):16–30. doi: 10.1016/s1388-1981(03)00059-3. [DOI] [PubMed] [Google Scholar]
  17. Hannun Yusuf A., Obeid Lina M. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem. 2002 May 13;277(29):25847–25850. doi: 10.1074/jbc.R200008200. [DOI] [PubMed] [Google Scholar]
  18. Howlett A. C., Barth F., Bonner T. I., Cabral G., Casellas P., Devane W. A., Felder C. C., Herkenham M., Mackie K., Martin B. R. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002 Jun;54(2):161–202. doi: 10.1124/pr.54.2.161. [DOI] [PubMed] [Google Scholar]
  19. Iwai Kazuya, Kondo Tadakazu, Watanabe Mitsumasa, Yabu Takeshi, Kitano Toshiyuki, Taguchi Yoshimitu, Umehara Hisanori, Takahashi Atsushi, Uchiyama Takashi, Okazaki Toshiro. Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis. J Biol Chem. 2003 Jan 2;278(11):9813–9822. doi: 10.1074/jbc.M201867200. [DOI] [PubMed] [Google Scholar]
  20. Kolesnick R. N., Krönke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol. 1998;60:643–665. doi: 10.1146/annurev.physiol.60.1.643. [DOI] [PubMed] [Google Scholar]
  21. Maher E. A., Furnari F. B., Bachoo R. M., Rowitch D. H., Louis D. N., Cavenee W. K., DePinho R. A. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001 Jun 1;15(11):1311–1333. doi: 10.1101/gad.891601. [DOI] [PubMed] [Google Scholar]
  22. Marsicano Giovanni, Moosmann Bemd, Hermann Heike, Lutz Beat, Behl Christian. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem. 2002 Feb;80(3):448–456. doi: 10.1046/j.0022-3042.2001.00716.x. [DOI] [PubMed] [Google Scholar]
  23. Martin Daniel, Salinas Marta, Fujita Naoya, Tsuruo Takashi, Cuadrado Antonio. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem. 2002 Sep 3;277(45):42943–42952. doi: 10.1074/jbc.M201070200. [DOI] [PubMed] [Google Scholar]
  24. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990 Aug 9;346(6284):561–564. doi: 10.1038/346561a0. [DOI] [PubMed] [Google Scholar]
  25. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995 Jun 29;50(1):83–90. doi: 10.1016/0006-2952(95)00109-d. [DOI] [PubMed] [Google Scholar]
  26. Mechoulam Raphael, Panikashvili David, Shohami Esther. Cannabinoids and brain injury: therapeutic implications. Trends Mol Med. 2002 Feb;8(2):58–61. doi: 10.1016/s1471-4914(02)02276-1. [DOI] [PubMed] [Google Scholar]
  27. Molina-Holgado Eduardo, Vela José M., Arévalo-Martín Angel, Almazán Guillermina, Molina-Holgado Francisco, Borrell José, Guaza Carmen. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci. 2002 Nov 15;22(22):9742–9753. doi: 10.1523/JNEUROSCI.22-22-09742.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993 Sep 2;365(6441):61–65. doi: 10.1038/365061a0. [DOI] [PubMed] [Google Scholar]
  29. Pertwee R. G. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin Investig Drugs. 2000 Jul;9(7):1553–1571. doi: 10.1517/13543784.9.7.1553. [DOI] [PubMed] [Google Scholar]
  30. Piomelli D., Giuffrida A., Calignano A., Rodríguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci. 2000 Jun;21(6):218–224. doi: 10.1016/s0165-6147(00)01482-6. [DOI] [PubMed] [Google Scholar]
  31. Rueda D., Galve-Roperh I., Haro A., Guzmán M. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol. 2000 Oct;58(4):814–820. doi: 10.1124/mol.58.4.814. [DOI] [PubMed] [Google Scholar]
  32. Shen M., Thayer S. A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol. 1998 Sep;54(3):459–462. doi: 10.1124/mol.54.3.459. [DOI] [PubMed] [Google Scholar]
  33. Sánchez C., Galve-Roperh I., Canova C., Brachet P., Guzmán M. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 1998 Sep 25;436(1):6–10. doi: 10.1016/s0014-5793(98)01085-0. [DOI] [PubMed] [Google Scholar]
  34. Sánchez C., Rueda D., Ségui B., Galve-Roperh I., Levade T., Guzmán M. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol Pharmacol. 2001 May;59(5):955–959. doi: 10.1124/mol.59.5.955. [DOI] [PubMed] [Google Scholar]
  35. Sánchez C., de Ceballos M. L., Gomez del Pulgar T., Rueda D., Corbacho C., Velasco G., Galve-Roperh I., Huffman J. W., Ramón y Cajal S., Guzmán M. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res. 2001 Aug 1;61(15):5784–5789. [PubMed] [Google Scholar]
  36. Willaime-Morawek S., Brami-Cherrier K., Mariani J., Caboche J., Brugg B. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience. 2003;119(2):387–397. doi: 10.1016/s0306-4522(02)00996-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES